https://scholars.houstonmethodist.org/en/publications/transforming-cancer-prevention-through-precision-medicine-and-imm/
Transforming cancer prevention through precision medicine and immune-oncology - Houston Methodist...
cancer preventionprecision medicineimmune oncologytransforming
https://dahshu.wildapricot.org/event-4071475
DahShu - Innovative adaptive design for immune-oncology trials
adaptive designimmune oncologyinnovativetrials
https://www.cellsignal.com/learn-and-support/videos-and-webinars/immunooncology-tumor-immune-mechanisms
Deciphering Immuno-Oncology: Targeting Cellular Mechanisms of the Tumor Immune Response | Cell...
Key signaling pathways modulate immune cell activation and tumor checkpoint evasion. Improved understanding of tumor microenvironment crosstalk and mechanisms...
immuno oncology
https://cordis.europa.eu/project/id/643130/results/es
Viruses, Immune stimulation and RNA Interference in Oncology Network | VIRION | Proyecto |...
Deliverables, publications, datasets, software, exploitable results
rna interferencevirusesimmunestimulation
https://medicalchannelasia.com/cancer/immune-checkpoint-inhibitors-in-oncology-nivolumab-opdivo/
Immune Checkpoint Inhibitors in Oncology: Nivolumab (Opdivo) - Medical Channel Asia
Mar 15, 2026 - Nivolumab (Opdivo) has been approved to treat several types of cancers. Find out the summary of the clinical trials leading to its approval.
immune checkpoint inhibitorsoncologynivolumabopdivomedical